BAX
BAXTER INTERNATIONAL INC
-0.20 (-0.85%)23.33USD2.1M成交股數12.1B市值–本益比(近四季)1.1股價營收比+5.3%營收年增(近四季)2026-10-29下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 3.0B+13% | 2.7B-2% | 2.8B+5% | 2.8B+4% | 2.6B+5% | 2.8B+1% | 2.7B+4% | 2.7B+4% | 2.5B | 2.7B | 2.6B | 2.6B |
| 營業成本 | 1.9B | 1.8B | 1.9B | 1.8B | 1.8B | – | 1.7B | 1.7B | 1.5B | – | 1.5B | 2.6B |
| 毛利 | 1.0B+20% | 891M-7% | 950M-8% | 991M-4% | 861M-10% | 959M-13% | 1.0B-2% | 1.0B+0% | 961M | 1.1B | 1.1B | 1.0B |
| 毛利率 | 34.9% | 33.0% | 33.5% | 35.3% | 32.8% | 34.8% | 38.3% | 38.3% | 38.6% | 40.3% | 40.6% | 39.8% |
| 研發費用 | 129M | 139M | 118M | 134M | 140M | – | 129M | 130M | 120M | – | 133M | 165M |
| 銷售管理費用 | 735M | 728M | 708M | 718M | 703M | – | 754M | 723M | 729M | – | 744M | 964M |
| 營業利益 | 217M+274% | 66.0M | 172M+11% | 191M+7% | 58.0M-50% | – | 155M-13% | 179M-1153% | 115M | – | 179M | −17.0M |
| 營業利益率 | 7.3% | 2.4% | 6.1% | 6.8% | 2.2% | – | 5.7% | 6.6% | 4.6% | – | 6.9% | -0.7% |
| 稅後淨利 | 126M0% | −15.0M-97% | −46.0M-133% | 91.0M-129% | 126M+241% | −512M-309% | 140M-94% | −314M+123% | 37.0M | 245M | 2.5B | −141M |
| 淨利率 | 4.3% | -0.6% | -1.6% | 3.2% | 4.8% | -18.6% | 5.2% | -11.7% | 1.5% | 9.0% | 96.5% | -5.4% |
| 稀釋 EPS | 0.24-4% | -0.03-97% | -0.09-133% | 0.18-130% | 0.25+257% | -1.00-308% | 0.27-95% | -0.61+118% | 0.07 | 0.48 | 4.93 | -0.28 |
| 稀釋股數 | 518M | 515M | 514M | 514M | 514M | – | 512M | 511M | 510M | – | 509M | 506M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 2.2B | 2.0B | 1.7B | 1.7B | 2.3B | 1.8B | 1.4B | 1.6B | 2.8B | 3.1B | 5.7B | 1.7B |
| 應收帳款 | 1.9B | 1.7B | 1.8B | 1.8B | 1.6B | 1.7B | 1.7B | 2.6B | 2.5B | 1.7B | 2.5B | 2.5B |
| 存貨 | 2.3B | 2.3B | 2.5B | 2.4B | 2.2B | 2.0B | 2.1B | 3.0B | 3.0B | 1.9B | 2.9B | 2.9B |
| 總資產 | 19.8B | 19.8B | 21.1B | 21.0B | 21.3B | 25.8B | 26.7B | 26.3B | 27.8B | 28.3B | 30.7B | 27.9B |
| 有息負債 | – | – | – | – | – | 13.2B | 10.4B | 10.4B | 11.1B | 13.9B | 14.1B | 14.3B |
| 總負債 | 13.6B | 13.8B | 13.9B | 13.8B | 14.3B | 18.8B | 18.7B | 18.6B | 19.6B | 19.8B | 22.5B | 22.3B |
| 股東權益 | 6.2B | 6.0B | 7.2B | 7.3B | 7.1B | 7.0B | 7.9B | 7.6B | 8.2B | 8.4B | 8.1B | 5.6B |
| 負債比 | 68.8% | 69.7% | 65.8% | 65.3% | 66.9% | 72.8% | 70.2% | 70.7% | 70.4% | 70.1% | 73.4% | 79.8% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | −11.4B | −9.0B | −8.9B | −8.3B | −10.8B | −8.4B | −12.6B |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 213M | – | – | −193M-218% | – | – | – | 163M | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | 237M | – | – | 247M | – | – | – | 271M | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | 5.0M | – | – | 87.0M | – | – | – | 147M | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 10.9B
| Medical Products And Therapies | 5.3B | 48.8% | +1.8% |
|---|---|---|---|
| Healthcare Systems And Technologies | 3.1B | 28.3% | +4.1% |
| Pharmaceuticals | 2.5B | 22.9% | +3.4% |
地區2025 年度 · 11.2B
| 美國 | 6.1B | 54.4% | +4.6% |
|---|---|---|---|
| Western Europe Canada Japan Australia And New Zealand | 3.7B | 33.2% | +8.5% |
| Eastern Europe Middle East Africa Latin America Asia | 1.4B | 12.4% | +3.3% |
| 美國以外 小計 | 5.1B | 45.6% | +7.0% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 11.2B | +5.7% | −957M | -8.5% | -1.87 | 332M |
| FY2024 | 10.6B | +2.7% | −649M | -6.1% | -1.27 | 573M |
| FY2023 | 10.4B | +3.0% | 2.7B | 25.6% | 5.23 | 1.3B |
| FY2022 | 10.1B | -17.2% | −2.4B | -24.2% | -4.83 | 834M |
| FY2021 | 12.1B | +4.1% | 1.3B | 10.6% | 2.53 | 1.5B |
| FY2020 | 11.7B | +2.7% | 1.1B | 9.4% | 2.13 | 1.2B |
| FY2019 | 11.4B | +2.4% | 1.0B | 8.8% | 1.93 | 1.4B |
| FY2018 | 11.1B | – | 1.5B | 13.9% | 2.83 | 1.4B |